CoChat

How strong is the association between maternal thrombophilia and adverse pregnancy outcome?

Alfirevic, Zarko, Roberts, Devender, Martlew, Vanessa · 2002 · European Journal of Obstetrics & Gynecology and Reproductive Biology

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Objective To determine whether inherited and acquired thrombophilias are associated with adverse obstetric complications.Study design A systematic review; studies where women with adverse obstetric complications were tested for one or more acquired and inherited thrombophilias were included.Main outcome measures Prevalence of thrombophilia in women with severe pre-eclampsia/eclampsia, severe placental abruption, intrauterine growth restriction or unexplained stillbirth.Results Compared with controls, placental abruption was more often associated with homozygous and heterozygous factor V Leiden mutation, heterozygous G20210A prothrombin gene mutation, homocysteinaemia, activated protein C resistance or anticardiolipin IgG antibodies. Women with pre-eclampsia/eclampsia were more likely to have heterozygous factor V Leiden mutation, heterozygous G20210A prothrombin gene mutation, homozygous MTHFR C677T mutation, protein C deficiency, protein S deficiency or activated protein C resistance compared with controls. Unexplained stillbirth, when compared with controls, was more often associated with heterozygous factor V Leiden mutation, protein S deficiency, activated protein C resistance, anticardiolipin IgG antibodies or lupus anticoagulant. Women with intrauterine growth restriction had a higher prevalence of heterozygous G20210A prothrombin gene mutation, homozygous MTHFR C677T gene mutation, protein S deficiency or anticardiolipin IgG antibodies than controls. There was wide heterogeneity in the prevalence of thrombophilia between the studies.Conclusions Women with adverse pregnancy outcome are more likely to have a positive thrombophilia screen but studies published so far are too small to adequately assess the true size of this association. Screening for thrombophilia should not become standard practice until clear evidence emerges that thromboprophylaxis during pregnancy improves perinatal outcome. Further research into the link between the observed association, causality and heterogeneity is required.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0301-2115(01)00496-1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 32 · Cited by 339

Research works printed but not linked: 1

  1. Review Manager (RevMan) [Computer programme]. Version 3.1 for Windows. Oxford, England: The Cochrane Collaboration, 1998 [three disks].

Metadata

Authors
Alfirevic, Z., Roberts, D., & Martlew, V.
Affiliations
  • Liverpool Women's Hospital (GB)
  • Royal Liverpool University Hospital (GB)
Venue
European Journal of Obstetrics & Gynecology and Reproductive Biology
Publisher
Elsevier BV
Published
2002-02
Volume
101
Issue
1
Pages
6-14
ISSN
  • 0028-2243 (ISSN-L)
  • 0301-2115
OpenAlex
W2115742352
Cited by
339
References
32
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 10 · 2021: 5 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 14 · 2016: 17 · 2015: 6 · 2014: 21 · 2013: 15 · 2012: 15
FWCI
3.53
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • European Journal of Obstetrics & Gynecology and Reproductive Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords
maternal thrombophilia, adverse pregnancy outcomes, factor V Leiden, prothrombin G20210A, MTHFR C677T polymorphism, protein S deficiency, protein C deficiency, activated protein C resistance, anticardiolipin antibodies, lupus anticoagulant, preeclampsia, placental abruption, fetal growth restriction, stillbirth, thrombophilia screening, thromboprophylaxis
MeSH terms
Abruptio Placentae, Eclampsia, Female, Fetal Death, Fetal Growth Retardation, Humans, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Hematologic, Pregnancy Outcome, MEDLINE, Thrombophilia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How strong is the association between maternal thrombophilia and adverse pregnancy outcome? https://app.cochat.ai/papers/10.1016/s0301-2115(01)00496-1
The paper
Alfirevic, Z., Roberts, D., & Martlew, V. (2002). How strong is the association between maternal thrombophilia and adverse pregnancy outcome? European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/s0301-2115(01)00496-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.